2Feigin VL,Forouzanfar MH,Krishnamurthi R,et al.Global and regional burden of stroke during 1990-2010:findings from the Global Burden of Disease Study 2010[J].Lancet,2014,383(9913):245.
3Ayerbe L,Ayis S,Wolfe CD,et al.Natural history,predictors and outcomes of depression after stroke:systematic review and meta-analysis[J].Br J Psychiatry,2013,202(1):14.
4Mak KK,Kong WY,Mak A,et al.Polymorphisms of the serotonin transporter gene and post-stroke depression:a meta-analysis[J].J Neurol Neurosurg Psychiatry,2013,84(3):322.
5Kim JM,Stewart R,Kang HJ,et al.A longitudinal study of SLC6A4 DNA promoter methylation and poststroke depression[J].J Psychiatr Res,2013,47(9):1222.
6Kronenberg G,Balkaya M,Prinz V,et al.Exofocal dopaminergic degeneration as antidepressant target in mouse model of poststroke depression[J].Biol Psychiatry,2012,72(4):273.
8Wang X,Li YH,Li MH,et al.Glutamate level detection by magnetic resonance spectroscopy in patients with post-stroke depression[J].Eur Arch Psychiatry Clin Neurosci,2012,262(1):33.
9Akinfiresoye L,Tizabi Y.Antidepressant effects of AMPA and ketamine combination:role of hippocampal BDNF,synapsin,and Mtor[J].Psychopharmacology (Berl),2013,230(2):291.
10de la Tremblaye PB,Raymond J,Milot MR,et al.Evidence of lasting dysregulation of neuroendocrine and HPA axis function following global cerebral ischemia in male rats and the effect of Antalarmin on plasma corticosterone level[J].Horm Behav,2014,65 (3):273.
